Age-Related Diabetes — Part 1
Age-Related Diabetes — Part 1
When blood sugar returns to normal, has the person truly become healthy?
Globally, approximately 25–30% of adults over the age of 65 are diagnosed with diabetes.
A fasting blood glucose level above 126 mg/dL,
or an HbA1c above 6.5%,
meets the criteria for Type 2 diabetes.
The moment the numbers cross that threshold,
you become a patient—
and blood sugar management begins (American Diabetes Association, 2023).
Modern medicine justifies these criteria through decades of epidemiological research.
Persistently elevated blood glucose damages blood vessels
and contributes to complications affecting:
- the kidneys
- eyes
- nerves
- cardiovascular system
The numbers do not lie.
But age-related diabetes tells a slightly different story.
Why Does Aging Disrupt Blood Sugar Regulation?
As aging progresses,
the body’s glucose regulation system changes in multiple ways simultaneously.
Increasing Insulin Resistance
One of the earliest changes is a gradual rise in insulin resistance.
Muscle and liver tissues become less responsive to insulin,
meaning the same amount of insulin can no longer lower blood glucose effectively.
At the same time, aging is associated with sarcopenia—
the progressive loss of muscle mass.
Because skeletal muscle is one of the body’s primary sites for glucose utilization,
loss of muscle itself reduces the body’s ability to regulate blood sugar (Chang & Halter, 2003).
Declining Beta-Cell Function
The pancreatic beta cells also undergo age-related decline.
As insulin resistance increases,
the pancreas must produce more insulin to maintain glucose control.
However, aging beta cells often cannot sustain this increased demand.
The combination of:
- rising insulin resistance
- declining beta-cell function
creates increasing glucose instability in elderly patients (Kalyani et al., 2017).
Chronic Low-Grade Inflammation
Aging also involves a gradual increase in inflammatory cytokines and oxidative stress.
These changes interfere directly with insulin signaling pathways.
Some researchers describe this state as “inflammaging”—
a convergence of aging and chronic inflammation (Franceschi & Campisi, 2014).
Clinical Features of Diabetes in Older Adults
In elderly patients, diabetes often presents differently.
The classic symptoms:
- excessive thirst
- frequent urination
- weight loss
may be less obvious.
Instead, diabetes may appear through symptoms that are difficult to distinguish from aging itself:
- fatigue
- cognitive decline
- reduced muscle strength
- recurrent infections
Because of this, diagnosis is often delayed.
The risk of hypoglycemia also increases.
Older adults may have reduced physiological responses to low blood sugar,
making overly aggressive glucose lowering potentially dangerous.
For this reason,
some clinical guidelines recommend more relaxed glycemic targets for elderly patients compared to younger adults (Kalyani et al., 2017).
What Modern Medicine Does
The approach of modern medicine is clear:
Maintain blood glucose within target range.
Metformin, insulin, SGLT2 inhibitors—
their mechanisms differ,
but the goal is the same:
keep HbA1c below a defined threshold.
This approach is undeniably effective.
Large clinical studies consistently show that blood sugar control reduces complications such as:
- retinopathy
- nephropathy
- neuropathy
(UKPDS Group, 1998)
But This Question Is Rarely Asked
A patient takes diabetes medication.
HbA1c decreases to 6.5%.
However—
- insulin resistance continues
- sarcopenia progresses
- chronic inflammation persists
- fatigue and cognitive decline often remain unresolved
So we return to the question:
When the numbers return to normal,
has the person truly become healthy?
This is not a rejection of modern medicine.
If modern medicine measures blood glucose as a number,
then perhaps the underlying physiological changes that led to elevated glucose
also need to be viewed through another lens.
What Comes Next
In the next article,
we will explore how Classical Medicine approaches this same question—
and what it observes beyond the numbers.
References
American Diabetes Association. (2023). Standards of Medical Care in Diabetes. Diabetes Care.
Chang AM, Halter JB. (2003). Aging and insulin secretion. American Journal of Physiology.
Franceschi C, Campisi J. (2014). Chronic inflammation and its potential contribution to age-associated diseases. Journals of Gerontology.
Kalyani RR, Golden SH, Cefalu WT. (2017). Diabetes and aging: unique considerations and goals of care. Diabetes Care.
UKPDS Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment. Lancet.
댓글
댓글 쓰기